APITBIO
APITBIO is a biotech company that specializes in antibody therapeutics research and development.
APITBIO
Industry:
Biopharma Biotechnology Product Research
Address:
Chongnoong Dong, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.apitbio.com
Total Employee:
11+
Status:
Active
Contact:
+82 2 6925 6570
Email Addresses:
[email protected]
Total Funding:
12.66 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API Content Delivery Network SSL By Default Font Awesome Apache Google
Similar Organizations
Apimeds
Apimeds is a biotechnology company that specializes in bee venom component drug development.
Genevide
Genevide is a biotech company that specializes in gene research and development.
ILIAS Biologics
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules.
Jiehua Biotechnology
Jiehua Biotechnology is a biopharmaceutical multinational company based on research and development.
Moogene Medi
Moogene Medi is a biotechnology company that specializes in gene therapy and development of drug delivery systems using nano-bio technology.
Vastu Vihar Biotech
Vastu Vihar Biotech is a drug development company that specializes in research and development work.
XuanZhu Pharma
XuanZhu Pharma is a biopharmaceutical company that focuses on drug research and development.
Investors List
LSK Investment
LSK Investment investment in Series A - APITBIO
UTC Investment Co.
UTC Investment Co. investment in Series A - APITBIO
Laguna Investment
Laguna Investment investment in Series A - APITBIO
Kolon Investment
Kolon Investment investment in Series A - APITBIO
KB Securities
KB Securities investment in Series A - APITBIO
Hyundai Venture Investment Corporation
Hyundai Venture Investment Corporation investment in Series A - APITBIO
Shinhan Venture Investment
Shinhan Venture Investment investment in Series A - APITBIO
Official Site Inspections
http://www.apitbio.com
- Host name: 50.148.160.34.bc.googleusercontent.com
- IP address: 34.160.148.50
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "APITBIO"
APITBIO - Crunchbase Company Profile & Funding
Organization. APITBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. APITBIO is a biotech …See details»
APITBIO Inc. - VentureRadar
"It is a biotech specializing in the development of antibody-based innovative new drugs established by the group. It specializes in the development of target-specific single or dual …See details»
APITBIO - Funding, Financials, Valuation & Investors - Crunchbase
APITBIO is a biotech company that specializes in antibody therapeutics research and development. New. Resources. Advanced Search ... Experience the new Crunchbase, …See details»
Apitbio 2025 Company Profile: Valuation, Funding & Investors
Apitbio General Information Description. Developer of a biotechnology platform designed to develop anti-cancer drugs. The company's platform develops anti-cancer drugs based on …See details»
APITBIO
이를 위해 에이피트바이오는 신규타겟 및 바이오마커 발굴 플랫폼과 자체 항체 라이브러리를 이용한 항체 발굴/최적화 기술 플랫폼 기반 First-in-Class 단클론항체 및 다중항체 신약을 개발하고 …See details»
APITBIO Co. Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore APITBIO Co. Ltd. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Infectious Diseases, Technology Platform:Bispecific antibody, …See details»
Apitbio - Overview, News & Similar companies | ZoomInfo.com
Who is Apitbio. It was established by a group of experts in the field of antibody development through cooperation among the industry, academia, research institute, and hospital in order to …See details»
BQURA | Companies - APITbio
Mar 24, 2025 Founded in 2018, APITBIO Co., Ltd. is a South Korean biotechnology company specializing in the development of innovative antibody-based therapeutics, particularly …See details»
APITBIO - Crunchbase
APITBIO is a biotech company that specializes in antibody therapeutics research and development. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. …See details»
APITBIO - Company Profile - Tracxn
APITBIO - Developer of antibody-based drug candidates for the treatment of cancer. from 4 investors. Founded by Seon-Joo Yoon in the year 2018. APITBIO has 2859 competitors.See details»
APIT BIO - Products, Competitors, Financials, Employees, …
APITBIO is developing monoclonal antibodies for anticancer and chronic hepatitis B treatment, CD3 T-cell engager bispecific antibodies, and ADC therapeutics based on its human synthetic …See details»
APIT BIO Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for APIT BIO Inc. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
APITBIO
APB-A001 관련 선도항체 특허 권리 양수 [생명공학연구원·강원대학교 → APITBIO] 08.22. 이중항체 공동연구개발계약 체결 [中-Biotheus社] ☞ 관련 기사 . 06.13. BIO International 2022 …See details»
APITBIO Co. Ltd. (APITBIO Co. Ltd.) - 药物管线_专利_临床试验_投 …
了解apitbio co. ltd. (apitbio co. ltd.)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:肿瘤，感染，技术平台:双特异性抗体，单克隆抗体，mrna，药物:apb-a001，apb …See details»
ApitBio chosen for a national new drug development ... - 더바이오
Jun 25, 2024 Last year, ApitBio received approval for domestic phase 1 clinical trials of ‘APB-A001’, a monoclonal antibody treatment candidate targeting CD171. With its selection for this …See details»
KOREA LIFE SCIENCE WEEK
APITBIO A platform-based biotech company dedicated to research and development of antibody-based innovative therapeutics. Established by a group of experts in the field of antibody …See details»
APITBIO - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. APITBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. About. APITBIO is …See details»
ApitBio registers CD171 targeted antibody for intractable solid …
Aug 29, 2024 Based on the patent, ApitBio is accelerating the development of 'first-in-class' anticancer drugs in multiple modalities (treatment approaches), including monoclonal …See details»
APB B001 - AdisInsight
02 Dec 2022 Early research in Solid tumours in South Korea (Parenteral) prior to December 2022 (ApitBio pipeline, December 2022) 16 Apr 2021 APITBIO acquires patent for targeted immune …See details»
Landmark Bio Acquired by Artis BioSolutions to Expand …
2 days ago The organization was established by leaders from academia, industry, and Boston's leading research hospitals. Together with Artis BioSolutions, Landmark Bio will enhance its …See details»